Understanding Austedo Teva: 6 Key Points Austedo, known generically as deutetrabenazine, is a prescription medication developed and manufactured by Teva....
Understanding Austedo Teva: 6 Key Points
Austedo, known generically as deutetrabenazine, is a prescription medication developed and manufactured by Teva Pharmaceutical Industries. It is specifically approved for the treatment of certain neurological conditions characterized by involuntary movements. This article outlines six key aspects to help users understand more about Austedo Teva, emphasizing the importance of professional medical consultation for all treatment decisions.
1. What is Austedo (Deutetrabenazine) by Teva?
Austedo is a brand-name prescription drug used to manage specific movement disorders. Its active ingredient, deutetrabenazine, works within the brain to help regulate certain neurotransmitters associated with involuntary movements. As a product of Teva Pharmaceutical Industries, it undergoes rigorous development and regulatory approval processes before being made available to patients. It is not an over-the-counter medication and requires a prescription from a qualified healthcare provider.
2. Approved Conditions for Austedo Teva
Austedo is indicated for two primary conditions by regulatory bodies such as the U.S. Food and Drug Administration (FDA):
Chorea Associated with Huntington's Disease
Huntington's disease is a progressive neurodegenerative disorder that can lead to involuntary jerky movements, known as chorea. Austedo is approved to help reduce the severity and frequency of these chorea movements, offering a management option for this challenging symptom.
Tardive Dyskinesia
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive body movements, often affecting the face, mouth, tongue, and limbs. It can be a side effect of certain medications, particularly older antipsychotic drugs. Austedo is approved to treat tardive dyskinesia in adults, helping to mitigate these troublesome movements.
3. The Role of Austedo in Managing Movement Disorders
Austedo works as a vesicular monoamine transporter 2 (VMAT2) inhibitor. This mechanism helps to decrease the amount of certain neurotransmitters, such as dopamine, released into the brain's synapses. By modulating these neurotransmitter levels, Austedo can help reduce the uncontrolled and excessive movements seen in conditions like chorea associated with Huntington's disease and tardive dyskinesia. Its action is focused on symptom management rather than curing the underlying condition.
4. Important Safety Information and Considerations
Like all prescription medications, Austedo comes with important safety information, potential side effects, and contraindications. It is crucial for patients to discuss their full medical history, including all existing conditions and medications, with their doctor before starting Austedo. Common side effects can include drowsiness, diarrhea, dry mouth, and fatigue. Serious side effects, though less common, can occur. Patients should never adjust their dosage or discontinue the medication without professional medical guidance. Regular monitoring by a healthcare professional is often recommended during treatment.
5. Teva Pharmaceutical Industries' Contribution
Teva Pharmaceutical Industries is a global pharmaceutical company committed to developing and manufacturing a wide range of medications. Their role in bringing Austedo to market highlights their focus on addressing unmet medical needs, particularly in neurological disorders. Teva is responsible for the research, development, manufacturing, and distribution of Austedo, adhering to strict quality and safety standards set by health authorities worldwide.
6. Navigating Treatment and Information
For individuals or caregivers seeking information about Austedo Teva, it is paramount to engage in open communication with healthcare providers. Doctors can provide personalized advice based on a patient's specific health profile, diagnose conditions, and determine if Austedo is an appropriate treatment option. Official product information, patient brochures, and prescribing information are also valuable resources, typically available through healthcare professionals or regulatory agency websites. Always consult a qualified medical professional for diagnosis, treatment, and medical advice.
Summary
Austedo (deutetrabenazine) from Teva Pharmaceutical Industries is a prescription medication primarily used to manage chorea associated with Huntington's disease and tardive dyskinesia. It works by acting as a VMAT2 inhibitor to help regulate brain neurotransmitters and reduce involuntary movements. Understanding Austedo's approved uses, mechanism, and important safety considerations is crucial for anyone considering or undergoing treatment. Due to the nature of this medication, professional medical consultation is essential for diagnosis, treatment decisions, and ongoing management to ensure safe and effective use.
